---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-22-000267"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:38:17.763160+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "medium"
source: SEC EDGAR
---

# Globus Medical stockholders approve 2021 Equity Incentive Plan amendment at annual meeting

## Summary
- At June 2, 2022 annual meeting, stockholders voted to approve amendment to the 2021 Equity Incentive Plan, effective immediately.
- Directors David C. Paul, Daniel T. Lemaitre, and Ann D. Rhoads elected to three-year terms with strong stockholder support.
- Deloitte & Touche LLP ratified as independent registered public accounting firm for fiscal 2022 (295,235,366 for).
- Non-binding advisory vote on named executive officer compensation approved (283,414,921 for).
- Plan amendment details (including share reserves, vesting, and award types) incorporated by reference from proxy statement filed April 21, 2022.

## SEC filing metadata
- accession: 0001562762-22-000267
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: medium
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276222000267/0001562762-22-000267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276222000267/gmed-20220602x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-22-000267
- JSON: https://secwatch.observer/filing/0001562762-22-000267.json
- Plain text: https://secwatch.observer/filing/0001562762-22-000267.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.